Lineage Cell Therapeutics Inc. — Director's Dealing 2016

Mar 6, 2016

_________ false

C002������� ����2Public.BIOTIME, INC10834Corporation no: 876343Stock Exchange/Market: -13041380HARBOR BAY PARKWAY 1301 , ALAMEDA 94502 , CALIFORNIA , U.S.ATel: 5105213390 , Fax: 5105213389E.mail address: info@biotimeinc.comReported via MAGNA: 06/03/2016              Time of broadcast: 08:33 08:32:23

Company site:		biotimeinc.com

Reference: 2016-02-000126

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Amendment of general statement of beneficial ownership (Form 13D). ����� ����� ���� ������ ������ �� ������� ����� ���, �������.
13D_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 03/03/2016
- - -
Name of the Signatory: : Gerzi Ilan , Position of Signatory in the reporting corporation: Attorney/Legal Counsel , Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ .
Harbor Bay Parkway 1301 Alameda 94502 Telephone: 510-5213390 , Facsimile: 510-5213389 , E-mail: Igerzi@pearlcohen.com 1